related

Mineralys Therapeutics Announces Pricing of Upsized $250.0 Million Underwritten Public Offering of Common Stock

September 02, 2025 21:33 ET  | Source: Mineralys Therapeutics, Inc. RADNOR, Pa., Sept. 02, 2025 (GLOBE NEWSWIRE) -- Mineralys Therapeutics,…

5 months ago

Cytokinetics Presents New Data Related to Aficamten at the European Society of Cardiology Congress 2025

Additional Data from MAPLE-HCM Shows Aficamten Improves Cardiac Structure and Function Compared to Metoprolol; Simultaneous Publication in the Journal of the American…

5 months ago

Voxtur Announces Financial Results Delay for Q2 2025

August 29, 2025 19:10 ET  | Source: Voxtur Analytics Corp. TORONTO and TAMPA, Fla., Aug. 29, 2025 (GLOBE NEWSWIRE) --…

5 months ago

U. S. Air Force Global Strike Command Reinstates the M18 Pistol

Confirms the safety, reliability, and durability of the P320 based M18 NEWINGTON, N.H., Aug. 27, 2025 /PRNewswire/ -- SIG SAUER…

5 months ago

Pheton Holdings Ltd Issues Statements Addressing Recent Market Activity and Misleading Rumors

BEIJING, China, Aug. 01, 2025 (GLOBE NEWSWIRE) -- Pheton Holdings Ltd (the “Company,” “we,” “our” or “Pheton”), a healthcare solution…

6 months ago

Egg Medical Announces U.S. Patent and Trademark Office Issues Final Rejection of All Claims in Rampart IC’s Radiation Shield Patent Following a Reexamination Challenge

ST. PAUL, Minn., July 30, 2025 /PRNewswire/ -- In a significant development in an ongoing legal dispute, the U.S. Patent and…

6 months ago

HOOKIPA Pharma Announces Intention to Voluntarily Delist and Deregister its Common Stock

July 18, 2025 16:05 ET  | Source: HOOKIPA Pharma Inc. NEW YORK and VIENNA, July 18, 2025 (GLOBE NEWSWIRE) --…

6 months ago

Via announces confidential submission of draft registration statement related to proposed public offering

NEW YORK, July 16, 2025 /PRNewswire/ -- Via Transportation, Inc. today announced that it has confidentially submitted a draft registration…

6 months ago

Ultragenyx Receives Complete Response Letter from FDA for UX111 AAV Gene Therapy to Treat Sanfilippo Syndrome Type A (MPS IIIA)

July 11, 2025 16:30 ET  | Source: Ultragenyx Pharmaceutical Inc. Complete Response Letter (CRL) cited specific chemistry, manufacturing and controls…

6 months ago

Erin M. Schuman Wins 2026 Nakasone Award for Discovery on Neural Synapse Function and Change During Formation of Memories

STRASBOURG, France, July 9, 2025 /PRNewswire/ -- The International Human Frontier Science Program Organization (HFSPO) is pleased to award the…

6 months ago